Neoscreen G6PD
Accurate quantification of Glucose-6-Phosphate Dehydrogenase in dried blood spot samples. Essential for early detection of G6PD deficiency.
Overview
Labsystems Diagnostics NeoScreen G6PD kit measures total Glucose-6-Phosphate Dehydrogenase (G6PD) in blood samples collected on filter paper. The test quantifies both free and glucose-released G6PD, providing reliable results for early screening and management of G6PD deficiency—a condition affecting over 400 million people worldwide, predominantly in Africa, the Middle East, and Southeast Asia.
Key Features
- Quantitative measurement of total G6PD from dried blood spots.
- High sensitivity and specificity for accurate screening.
- Streamlined workflow for neonatal and high-volume testing.
- Compatible with standard laboratory microplate formats.
- Supports early diagnosis and intervention in G6PD-deficient patients.
Technical Specifications
- Sample Type : Dried blood spot (DBS)
- Detection Method : Fluorometric enzyme assay
- Analysis : Quantitative determination of total G6PD
- Workflow : Compatible with automated microplate readers
IS Modules
- Integrated quality controls for assay validation.
- Data management and traceability support.
- Customizable reporting modules for laboratory needs.